14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.21 $4.94 Friday, 3rd May 2024 RVNC stock ended at $3.95. This is 4.77% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.90% from a day low at $3.88 to a day high of $4.07.
90 days $3.21 $7.56
52 weeks $3.21 $37.98

Historical Revance Therapeutics prices

Date Open High Low Close Volume
May 03, 2024 $3.92 $4.07 $3.88 $3.95 1 358 767
May 02, 2024 $3.91 $3.99 $3.66 $3.77 1 241 192
May 01, 2024 $3.75 $4.06 $3.65 $3.80 1 957 363
Apr 30, 2024 $3.62 $3.78 $3.51 $3.61 2 110 395
Apr 29, 2024 $3.45 $3.77 $3.41 $3.69 3 183 185
Apr 26, 2024 $3.30 $3.56 $3.21 $3.40 2 269 826
Apr 25, 2024 $3.50 $3.50 $3.23 $3.29 2 601 899
Apr 24, 2024 $3.64 $3.75 $3.54 $3.57 1 779 405
Apr 23, 2024 $3.64 $3.81 $3.62 $3.66 1 587 204
Apr 22, 2024 $3.83 $3.87 $3.62 $3.64 1 602 471
Apr 19, 2024 $3.80 $3.87 $3.71 $3.78 1 625 209
Apr 18, 2024 $3.75 $3.82 $3.63 $3.79 1 574 318
Apr 17, 2024 $3.87 $3.90 $3.74 $3.76 1 720 375
Apr 16, 2024 $3.97 $3.97 $3.72 $3.81 2 408 032
Apr 15, 2024 $4.08 $4.19 $3.96 $3.97 2 107 538
Apr 12, 2024 $4.39 $4.42 $4.10 $4.13 1 570 653
Apr 11, 2024 $4.45 $4.53 $4.21 $4.44 1 615 424
Apr 10, 2024 $4.47 $4.52 $4.31 $4.41 1 575 803
Apr 09, 2024 $4.49 $4.94 $4.47 $4.69 1 772 619
Apr 08, 2024 $4.38 $4.47 $4.36 $4.45 789 949
Apr 05, 2024 $4.37 $4.46 $4.33 $4.41 1 256 331
Apr 04, 2024 $4.65 $4.67 $4.36 $4.41 1 039 816
Apr 03, 2024 $4.52 $4.64 $4.37 $4.55 1 304 372
Apr 02, 2024 $4.61 $4.63 $4.45 $4.51 1 685 480
Apr 01, 2024 $4.99 $4.99 $4.67 $4.73 1 085 879
Click to get the best stock tips daily for free!

About Revance Therapeutics

Revance Therapeutics Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials for the treatment of glabellar (frown) lines and cervical dystonia; is in phase II clinical trials to tre... RVNC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT